The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prognostic models for advanced melanoma patients treated with anti-PD-1 monotherapy.
 
Xue Bai
No Relationships to Disclose
 
Michelle S. Kim
No Relationships to Disclose
 
Gyulnara G. Kasumova
No Relationships to Disclose
 
Justine Vanessa Cohen
No Relationships to Disclose
 
Donald P. Lawrence
No Relationships to Disclose
 
Christine Freedman
No Relationships to Disclose
 
Riley Fadden
No Relationships to Disclose
 
Krista M. Rubin
Consulting or Advisory Role - Array BioPharma; Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis
 
Tatyana Sharova
No Relationships to Disclose
 
Keith Flaherty
Stock and Other Ownership Interests - Clovis Oncology; Loxo; Strata Oncology; X4 Pharma
Consulting or Advisory Role - Adaptimmune; Aeglea Biotherapeutics; Amgen; Asana Biosciences; Bristol-Myers Squibb; Genentech; Incyte; Lilly; Loxo; Merck; Novartis; Oncoceutics; Roche; Sanofi; Shattuck Labs; Tolero Pharmaceuticals
Research Funding - Novartis; Sanofi
 
Ryan J. Sullivan
Honoraria - Roche/Genentech
Consulting or Advisory Role - ACI Clinical; Amgen; Array BioPharma; Biodesix; BiolineRx; Compugen; Merck; Novartis; Replimmune; Syndax; Takeda; WorldCare Clinical, LLC
Research Funding - Aeglea Biotherapeutics (Inst); Amgen (Inst); Asana Biosciences (Inst); BioMed Valley Discoveries (Inst); Deciphera (Inst); Lilly (Inst); Merck (Inst); Moderna Therapeutics (Inst); Roche/Genentech (Inst); Sanofi (Inst)
Other Relationship - Boehringer Ingelheim
 
Genevieve Marie Boland
Research Funding - Takeda